News > Remdesivir does not help hospitalised Covid-19 patients: WHO study

Remdesivir does not help hospitalised Covid-19 patients: WHO study

Anti-viral drug Remdesivir has little or no effect in the recovery and mortality of hospitalized Covid-19 patients, said a World Health Organisation (WHO) study, giving a big blow to the hope that the drug from US-based Gilead Sciences raised in combating the pandemic.

The results from the study indicate that remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon regimens appeared to have little or no effect on 28-day mortality or the in-hospital course of Covid-19 among hospitalised patients.